The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors for emergency room and hospital care for patients with advanced solid tumors on immune checkpoint inhibitor therapy.
 
Anish B Parikh
No Relationships to Disclose
 
George Mellgard
No Relationships to Disclose
 
Qian Qin
No Relationships to Disclose
 
Vaibhav G. Patel
No Relationships to Disclose
 
Bo Wang
Stock and Other Ownership Interests - ABION; Bellicum Pharmaceuticals; PhaseRx; Unum Therapeutics
Consulting or Advisory Role - Sanofi
 
Xiaobo Zhong
No Relationships to Disclose
 
Amanda Leiter
No Relationships to Disclose
 
Emily J. Gallagher
Consulting or Advisory Role - Novartis
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Aileron Therapeutics; Astellas Pharma; AstraZeneca; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; GlaxoSmithKline; Incyte; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
William K. Oh
Leadership - checkpoint Sciences
Stock and Other Ownership Interests - Bellicum Pharmaceuticals
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; checkpoint Sciences; HUYA Bioscience International; Janssen; Sanofi; Sema4; TeneoBio; TYME
Research Funding - Constellation Pharmaceuticals; Sotio (Inst)
 
Steven K. Clinton
Research Funding - American Cancer Society; American Institute for Cancer Research; Department of Defense-Prostate Cancer Research Program; NIH; The National Cattleman's Beef Association; United States Department of Agriculture
 
Amir Mortazavi
Honoraria - Motive Medical Intelligence
Consulting or Advisory Role - Debiopharm Group; Seagen
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Paul Monk
Honoraria - Sanofi/Aventis
Consulting or Advisory Role - Dendreon
Speakers' Bureau - Janssen
 
Edmund Folefac
No Relationships to Disclose
 
Ming Yin
No Relationships to Disclose
 
Yuanquan Yang
No Relationships to Disclose
 
Che-Kai Tsao
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Eisai; Pfizer